In 2022, the FDA provided draft guidance around diversity plans for sponsors to improve the enrollment of clinical trial participants from underrepresented racial and ethnic ...
We have seen clinical research sites accelerate their patient enrollment timeline by four weeks. We have also seen sites enroll 41% more patients in a clinical trial than industry ...
Patient enrollment is a major bottleneck for clinical trials — but it doesn’t have to be. Sponsors can take steps to remove barriers to enrollment well before a trial is underway, ...
.png?width=64&name=OST%20Transparent%20(1).png)
